Evidence map›Paper›PMID 39985599›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion.

Morgana D'Ottavi, Ilenia Scialabba, Duong Thi Huong, Hoang Thi Giang, Pham Minh Khue, Vu Hai Vinh, Roselyne Vallo, Laurent Michel, Delphine Rapoud, Catherine Quillet and 9 more

Abstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Morgana D'Ottavi *Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Ilenia Scialabba *Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Duong Thi HuongFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam, 04212, USA.
Hoang Thi GiangFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam, 04212, USA.
Pham Minh KhueFaculty of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam, 04212, USA.
Vu Hai VinhInfectious & Tropical Diseases Department, Viet Tiep Hospital, Viet Nam, Hai Phong, 04708, USA.
Roselyne ValloPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Laurent MichelCESP UMR1018, Paris Saclay University, French Red Cross, Pierre Nicole center, Paris, 75005, France.
Delphine RapoudPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Catherine QuilletPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Nham Thi Tuyet ThanhSupporting Community Development Initiatives, Viet Nam, Hanoi, 11513, Vietnam.
Juliette BouniolPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France.
Khuat Thi Hai OanhSupporting Community Development Initiatives, Viet Nam, Hanoi, 11513, Vietnam.
Jonathan FeelmyerSchool of Global Public Health, New York University, New York, NY, 10003, USA.
Philippe Vande PerrePathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, 34394, France.
Didier LaureillardPathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, CHU Nîmes, Montpellier, 34394, France.
Don Des JarlaisSchool of Global Public Health, New York University, New York, NY, 10003, USA.
Nicolas Nagot *Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, 34394, France. n-nagot@chu-montpellier.fr.
Jean-Pierre Molès *Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Montpellier, 34394, France. jean-pierre.moles@inserm.fr.

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet NamR01DA041978 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C · 2016 to 2020
$4.9M
Agence Nationale de Recherche sur le SIDA et les hépatites virales #12299 & #12353NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA041978US National Institute of Drug Abuse #P30DA011041 & #R01DA041978
6 · The paper itself

Abstract

purposeGenital Herpes Simplex Virus-2 (HSV-2) epidemic is highly active worldwide and can be associated with severe morbidity and mortality. This study aimed to estimate the prevalence and incidence of HSV-2 infection among a vulnerable population of active heroin injectors in Hai Phong, Vietnam, and identify associated risk factors.

methodAssociations between HSV-2 infection and socio-demographic characteristics and sexual behaviors were explored in a univariable analysis of seroprevalence. Risk factors were defined using a multivariable Poisson regression accounting for time of follow-up.

resultsHSV-2 seroprevalence at baseline was 20.8% [95%CI: 17.8-22.2] for the 1281 men people who inject drugs (PWID), and 67.4% [95%CI: 60.1-74.1] for the 184 women PWID. For HSV-2 incidence, we accumulated a follow-up time of 1156.0 and 85.9 years for men and women, respectively. Standardised incidence rate was 4 [95%CI: 2.2-7.5] and 17.5 [95%CI: 5.7-53.8] infections per 100 person-years for men and women, respectively. Factors independently associated with HSV-2 seroconversion were HIV and injecting drug use for 5-10 years for men, and declared an uncontrolled HIV viral load and the use of street methadone.

conclusionHigh HSV-2 prevalence and incidence among PWID in Hai Phong point out the burden of sexually transmissible infections in this population. Together these results advocate for a reinforcement of HSV-2 care and prevention in this population and identify PWID as future beneficiaries of upcoming therapeutic/prophylactic vaccines.

Indexed as

Herpes GenitalisHerpesvirus 2, HumanSubstance Abuse, IntravenousAdultFemaleHumansIncidenceMaleMiddle AgedPrevalenceRisk FactorsSeroconversionSeroepidemiologic StudiesSexual BehaviorVietnamYoung AdultHSV-2IncidenceInjecting drug usersPrevalenceVulnerable population

Identifiers

PMID39985599
PMCPMC12062056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.